These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 20226165)
21. Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses. Yu JS; Tseng CK; Lin CK; Hsu YC; Wu YH; Hsieh CL; Lee JC Antiviral Res; 2017 Jan; 137():49-57. PubMed ID: 27847245 [TBL] [Abstract][Full Text] [Related]
22. Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1. Der Sarkissian S; Cailhier JF; Borie M; Stevens LM; Gaboury L; Mansour S; Hamet P; Noiseux N Br J Pharmacol; 2014 Dec; 171(23):5265-79. PubMed ID: 25041185 [TBL] [Abstract][Full Text] [Related]
23. Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule. Trott A; West JD; Klaić L; Westerheide SD; Silverman RB; Morimoto RI; Morano KA Mol Biol Cell; 2008 Mar; 19(3):1104-12. PubMed ID: 18199679 [TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity. Sun M; Tang Y; Ding T; Liu M; Wang X Fitoterapia; 2014 Jan; 92():1-8. PubMed ID: 24144799 [TBL] [Abstract][Full Text] [Related]
25. Celastrol regulates innate immunity response via NF-κB and Hsp70 in human retinal pigment epithelial cells. Paimela T; Hyttinen JM; Viiri J; Ryhänen T; Karjalainen RO; Salminen A; Kaarniranta K Pharmacol Res; 2011 Nov; 64(5):501-8. PubMed ID: 21683142 [TBL] [Abstract][Full Text] [Related]
26. Peptide deformylase inhibitor actinonin reduces celastrol's HSP70 induction while synergizing proliferation inhibition in tumor cells. Peng B; Zhang X; Cao F; Wang Y; Xu L; Cao L; Yang C; Li M; Uzan G; Zhang D BMC Cancer; 2014 Mar; 14():146. PubMed ID: 24589236 [TBL] [Abstract][Full Text] [Related]
27. Celastrol prevents circulatory failure via induction of heme oxygenase-1 and heat shock protein 70 in endotoxemic rats. Wang YL; Lam KK; Cheng PY; Lee YM J Ethnopharmacol; 2015 Mar; 162():168-75. PubMed ID: 25571843 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of IKKβ by celastrol and its analogues - an in silico and in vitro approach. Veerappan K; Natarajan S; Ethiraj P; Vetrivel U; Samuel S Pharm Biol; 2017 Dec; 55(1):368-373. PubMed ID: 27931154 [TBL] [Abstract][Full Text] [Related]
29. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis. Divya T; Velavan B; Sudhandiran G Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529 [TBL] [Abstract][Full Text] [Related]
30. Celastrols as inducers of the heat shock response and cytoprotection. Westerheide SD; Bosman JD; Mbadugha BN; Kawahara TL; Matsumoto G; Kim S; Gu W; Devlin JP; Silverman RB; Morimoto RI J Biol Chem; 2004 Dec; 279(53):56053-60. PubMed ID: 15509580 [TBL] [Abstract][Full Text] [Related]
31. Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway. Huang L; Zhang Z; Zhang S; Ren J; Zhang R; Zeng H; Li Q; Wu G Int J Mol Med; 2011 Mar; 27(3):407-15. PubMed ID: 21249310 [TBL] [Abstract][Full Text] [Related]
32. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway. Tozawa K; Sagawa M; Kizaki M Int J Oncol; 2011 Nov; 39(5):1117-22. PubMed ID: 21850367 [TBL] [Abstract][Full Text] [Related]
33. A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells. Zhang T; Hamza A; Cao X; Wang B; Yu S; Zhan CG; Sun D Mol Cancer Ther; 2008 Jan; 7(1):162-70. PubMed ID: 18202019 [TBL] [Abstract][Full Text] [Related]
34. Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones. Yang C; Swallows CL; Zhang C; Lu J; Xiao H; Brady RO; Zhuang Z Proc Natl Acad Sci U S A; 2014 Jan; 111(1):249-54. PubMed ID: 24351928 [TBL] [Abstract][Full Text] [Related]
35. Celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effect. Kim Y; Kim K; Lee H; Han S; Lee YS; Choe J; Kim YM; Hahn JH; Ro JY; Jeoung D Eur J Pharmacol; 2009 Jun; 612(1-3):131-42. PubMed ID: 19356729 [TBL] [Abstract][Full Text] [Related]
36. Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications. Wagh PR; Desai P; Prabhu S; Wang J Front Pharmacol; 2021; 12():673209. PubMed ID: 34177584 [TBL] [Abstract][Full Text] [Related]
37. Celastrol ameliorates autoimmune disorders in Trex1-deficient mice. Liu Y; Xiao N; Du H; Kou M; Lin L; Huang M; Zhang S; Xu S; Li D; Chen Q Biochem Pharmacol; 2020 Aug; 178():114090. PubMed ID: 32565148 [TBL] [Abstract][Full Text] [Related]
38. Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells. Li X; Zhu G; Yao X; Wang N; Hu R; Kong Q; Zhou D; Long L; Cai J; Zhou W Onco Targets Ther; 2018; 11():8977-8985. PubMed ID: 30588010 [TBL] [Abstract][Full Text] [Related]
39. Competitive profiling of celastrol targets in human cervical cancer HeLa cells via quantitative chemical proteomics. Zhou Y; Li W; Wang M; Zhang X; Zhang H; Tong X; Xiao Y Mol Biosyst; 2016 Dec; 13(1):83-91. PubMed ID: 27819370 [TBL] [Abstract][Full Text] [Related]
40. Treatment of obesity with celastrol. Liu J; Lee J; Salazar Hernandez MA; Mazitschek R; Ozcan U Cell; 2015 May; 161(5):999-1011. PubMed ID: 26000480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]